Fri, February 28, 2025
[ Fri, Feb 28th 2025 ]: Fortune
Elon Musk and DOGE 'weaponized' the U.S. Digital Service and betrayed its mission, insiders say
[ Fri, Feb 28th 2025 ]: WVTF
Tech's Innovation Campus opens its doors in Alexandria
[ Fri, Feb 28th 2025 ]: CNET
Scammers Are Using Voice Clips to Create AI Clones. Here's How to Stay Safe
[ Fri, Feb 28th 2025 ]: MSN
Officials Tout Potential Of Innovation Campus At Ribbon Cutting
Sun, February 23, 2025
[ Sun, Feb 23rd 2025 ]: Tuko
Electrical and Electronics Engineering course requirements and universities offered
[ Sun, Feb 23rd 2025 ]: CNET
NASA's Army of Autonomous Lunar Robots
[ Sun, Feb 23rd 2025 ]: manilatimes
DOST launches first science-travel show on TV
[ Sun, Feb 23rd 2025 ]: MSN
A Million Nano Drones: What Could They Do?
[ Sun, Feb 23rd 2025 ]: businessday
Five best countries to study data science globally
Sat, February 22, 2025
[ Sat, Feb 22nd 2025 ]: ScienceAlert
Strange Metal From Beyond Our World Found in an Ancient Treasure Stash
[ Sat, Feb 22nd 2025 ]: Indiatimes
5 mysterious places on Earth that remain unexplained to this day
[ Sat, Feb 22nd 2025 ]: Salon
Navigating chaos: The science of uncertainty and .. w to build resilience in a constant state of flux
[ Sat, Feb 22nd 2025 ]: SpaceNews
China launches ChinaSat-10R communications satellite from Xichang
[ Sat, Feb 22nd 2025 ]: NextBigFuture
Why is a Natural Gas Turbine Company Using Solar in Its Company Name?
[ Sat, Feb 22nd 2025 ]: NDTV
University Chancellor Arrested In Assam For 'Malpractices' In CBSE Exam
[ Sat, Feb 22nd 2025 ]: Couriermail
Prime Minister Anthony Albanese has committed $37m to Tasmania's salmon industry
[ Sat, Feb 22nd 2025 ]: Forbes
3 Science Challenges In 2025 That Might Surprise You
[ Sat, Feb 22nd 2025 ]: Wired
Security News This Week: $1.4 Billion Stolen From ByBit in Biggest Crypto Theft Ever
[ Sat, Feb 22nd 2025 ]: businessday
Top 10 universities attended by the world's richest people
[ Sat, Feb 22nd 2025 ]: Tagtik
In France, this new military aircraft will dominate the skies
[ Sat, Feb 22nd 2025 ]: ABC
Here are all the federal agencies where workers are being fired
[ Sat, Feb 22nd 2025 ]: MSN
Science news this week: AI mind readers and an ancient Egyptian tomb
[ Sat, Feb 22nd 2025 ]: valleycentral
STEM hosts its 10th annual South Texas STEM Summit
[ Sat, Feb 22nd 2025 ]: President
Plenary meeting of the Future Technologies Forum
Fri, February 21, 2025
[ Fri, Feb 21st 2025 ]: YourTango
11 Things We Were Taught As Kids That Turned Out To Be Completely Wrong
[ Fri, Feb 21st 2025 ]: Hoodline
Cedarwood Elementary Pioneers STEM Education with TECHie Club for Young Students
[ Fri, Feb 21st 2025 ]: ArtNews
North America's First and Only Leonardo da Vinci Museum is Slated to Open in Colorado
[ Fri, Feb 21st 2025 ]: canton
SUNY Canton Researchers Say Lightweight Concrete Homes Could Survive Wildfires
[ Fri, Feb 21st 2025 ]: CNN
House Democrats raise 'deep alarm' over potential DOGE conflict of interest at NASA
[ Fri, Feb 21st 2025 ]: Wired
The Ozempic Shortage Is Over
[ Fri, Feb 21st 2025 ]: TechCrunch
The real reason why oil and gas companies are bullish on carbon capture
[ Fri, Feb 21st 2025 ]: IFLScience
What Is That Horrible Sound When You Crack Your Knuckles?
[ Fri, Feb 21st 2025 ]: CNET
Did You Know Sun Exposure Helps You Sleep Better? Here's How It Worked for Me
[ Fri, Feb 21st 2025 ]: kennesaw
Kennesaw State researcher earns American Heart As .. for innovative study on heart disease diagnostics
[ Fri, Feb 21st 2025 ]: businessday
Here are top Nigeria's most prestigious universities in 2025 rankings
[ Fri, Feb 21st 2025 ]: Reuters
Fact Check: Image of armed hospital ambush is AI, not evidence of disorder in UK
[ Fri, Feb 21st 2025 ]: WKBW
Trocaire College opens new facility for veterinary science program
[ Fri, Feb 21st 2025 ]: Forbes
Material Science With Circular Economy As The Centerpiece
[ Fri, Feb 21st 2025 ]: SpaceNews
AI to power China's mission to the edges of the solar system
[ Fri, Feb 21st 2025 ]: cnbctv18
India expands scope of key critical mineral classification to boost high-tech applications
[ Fri, Feb 21st 2025 ]: NextBigFuture
A Debt Spiral and US Financial Collapse in the 2030s
[ Fri, Feb 21st 2025 ]: Zawya
Science, Technology and Innovation on presentatio .. a's National Astro-Tourism Strategy to Parliament
[ Fri, Feb 21st 2025 ]: MSN
Electric smelting furnace technology, hydrogen fuel alternatives for blast furnaces: Experts
Thu, February 20, 2025
[ Thu, Feb 20th 2025 ]: Reuters
Trump Pulls US Out Of Key Global Climate Assessment: Report
[ Thu, Feb 20th 2025 ]: BBC
Will quantum computers disrupt critical infrastructure?
[ Thu, Feb 20th 2025 ]: Wired
The Odds of a City-Killing Asteroid Hitting Earth Keep Rising
[ Thu, Feb 20th 2025 ]: MSN
Topological quantum processor uses Majorana zero modes for fault-tolerant computing
[ Thu, Feb 20th 2025 ]: Yahoo
Mechatronics Meltdown: BBCC event highlights technology with fun

NICE green lights two blood cancer therapies for NHS use

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. ghts-two-blood-cancer-therapies-for-nhs-use.html
  Print publication without navigation Published in Science and Technology on by MSN
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains editorial commentary or bias from the source
BMS' Breyanzi and Amgen's Blincyto will now be available to patients in England with certain types of blood cancer.
The UK's National Institute for Health and Care Excellence (NICE) has approved two new therapies, mosunetuzumab (Lunsumio) and glofitamab (Columvi), for treating specific types of blood cancer within the NHS. These treatments are targeted at adults with relapsed or refractory follicular lymphoma (FL) who have undergone at least two prior lines of systemic therapy. Mosunetuzumab is administered as a fixed course over 8 cycles, while glofitamab is given until disease progression or unacceptable toxicity. Both drugs work by engaging the body's immune system to attack cancer cells, offering a new hope for patients with this aggressive form of lymphoma. The approval follows a recommendation from NICE's Highly Specialised Technologies committee, highlighting the potential of these therapies to significantly improve patient outcomes.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biology/nice-green-lights-two-blood-cancer-therapies-for-nhs-use/ar-AA1zxweQ ]